Please assess the completion status of the following clinical trial:

Trial Title: Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. The subject's written informed consent had to be obtained prior to inclusion.~2. Male or female ambulatory subjects with an age of 18 to 85 years planned to undergo a complete colonoscopy for colon cancer screening~3. Willing, able and competent to complete the entire procedure and to comply with study instructions~4. Females of childbearing potential had to employ an adequate method of contraception~Exclusion Criteria:~1. Ileus~2. Intestinal obstruction or perforation~3. Toxic megacolon~4. History of colonic resection~5. Requirement for permanent medication and associated stable serum concentrations (e.g. neuroleptic drugs)~6. Congestive heart failure (NYHA III + IV)~7. Acute life threatening cardiovascular disease~8. Untreated or uncontrolled arterial hypertension (max. \> 170 mmHg and min \> 100 mmHg)~9. Known moderate to severe renal insufficiency~10. Severe renal failure~11. Severe liver failure~12. Known glucose 6 phosphatase dehydrogenase deficiency~13. Known phenylketonuria~14. Known hypersensitivity to polyethylene glycols, NaP and/or Vitamin C~15. Concurrent participation in an investigational drug study or participation within 30 days of study entry~16. Females who were pregnant, nursing or planning a pregnancy. Females of child bearing potential not using reliable methods of contraception~17. Subject had a condition or was in a situation, which in the investigators opinion might have put the subject at significant risk, might confound the study results, or might interfere significantly.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): 2L gut cleansing solution
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).